Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BEAM |
---|---|---|
09:32 ET | 16432 | 23.1854 |
09:34 ET | 1934 | 23.29 |
09:36 ET | 2431 | 23.28 |
09:38 ET | 1850 | 23.245 |
09:39 ET | 1371 | 23.19 |
09:41 ET | 2188 | 23.25 |
09:43 ET | 3423 | 23.09 |
09:45 ET | 886 | 23.105 |
09:48 ET | 2300 | 23.0975 |
09:50 ET | 1878 | 23.165 |
09:52 ET | 3350 | 23.28 |
09:54 ET | 1677 | 23.27 |
09:56 ET | 2000 | 23.22 |
09:57 ET | 1271 | 23.22 |
09:59 ET | 942 | 23.232 |
10:01 ET | 6151 | 23.275 |
10:03 ET | 2935 | 23.415 |
10:06 ET | 1450 | 23.5782 |
10:08 ET | 1570 | 23.34 |
10:10 ET | 3526 | 23.47 |
10:12 ET | 1202 | 23.514 |
10:14 ET | 1120 | 23.49 |
10:15 ET | 500 | 23.47 |
10:17 ET | 759 | 23.3928 |
10:19 ET | 300 | 23.46 |
10:21 ET | 1777 | 23.57 |
10:24 ET | 635 | 23.37 |
10:26 ET | 400 | 23.39 |
10:28 ET | 1030 | 23.4 |
10:30 ET | 100 | 23.435 |
10:32 ET | 110 | 23.406 |
10:35 ET | 600 | 23.41 |
10:37 ET | 2305 | 23.375 |
10:39 ET | 100 | 23.41 |
10:42 ET | 400 | 23.47 |
10:44 ET | 500 | 23.46 |
10:46 ET | 800 | 23.475 |
10:50 ET | 1629 | 23.57 |
10:51 ET | 1649 | 23.56 |
10:53 ET | 1000 | 23.43 |
10:55 ET | 700 | 23.43 |
10:57 ET | 300 | 23.39 |
11:00 ET | 300 | 23.35 |
11:02 ET | 325 | 23.35 |
11:04 ET | 1298 | 23.41 |
11:06 ET | 1590 | 23.49 |
11:08 ET | 500 | 23.455 |
11:09 ET | 1863 | 23.36 |
11:11 ET | 398 | 23.3 |
11:13 ET | 100 | 23.35 |
11:15 ET | 361 | 23.28 |
11:18 ET | 700 | 23.335 |
11:20 ET | 855 | 23.36 |
11:22 ET | 833 | 23.345 |
11:24 ET | 1125 | 23.255 |
11:26 ET | 400 | 23.2 |
11:27 ET | 600 | 23.2323 |
11:29 ET | 500 | 23.17 |
11:31 ET | 200 | 23.165 |
11:33 ET | 114 | 23.18 |
11:36 ET | 4790 | 23.25 |
11:38 ET | 1300 | 23.24 |
11:40 ET | 7724 | 23.27 |
11:42 ET | 4913 | 23.28 |
11:44 ET | 925 | 23.3 |
11:45 ET | 1200 | 23.3 |
11:47 ET | 2377 | 23.27 |
11:49 ET | 200 | 23.24 |
11:51 ET | 200 | 23.2782 |
11:54 ET | 500 | 23.2627 |
11:56 ET | 200 | 23.235 |
11:58 ET | 200 | 23.24 |
12:00 ET | 600 | 23.27 |
12:02 ET | 830 | 23.2709 |
12:03 ET | 200 | 23.27 |
12:05 ET | 1600 | 23.19 |
12:07 ET | 770 | 23.26 |
12:09 ET | 100 | 23.28 |
12:12 ET | 823 | 23.28 |
12:14 ET | 200 | 23.24 |
12:16 ET | 1064 | 23.26 |
12:18 ET | 900 | 23.27 |
12:20 ET | 549 | 23.3 |
12:21 ET | 200 | 23.23 |
12:23 ET | 300 | 23.27 |
12:25 ET | 1000 | 23.3101 |
12:27 ET | 200 | 23.33 |
12:30 ET | 900 | 23.36 |
12:32 ET | 1400 | 23.27 |
12:36 ET | 652 | 23.25 |
12:38 ET | 352 | 23.215 |
12:39 ET | 400 | 23.21 |
12:41 ET | 600 | 23.23 |
12:43 ET | 3000 | 23.22 |
12:45 ET | 523 | 23.194 |
12:48 ET | 200 | 23.18 |
12:50 ET | 1220 | 23.23 |
12:52 ET | 880 | 23.215 |
12:54 ET | 2230 | 23.218 |
12:56 ET | 1200 | 23.205 |
12:57 ET | 840 | 23.16 |
12:59 ET | 1830 | 23.11 |
01:01 ET | 4025 | 23.1451 |
01:03 ET | 1340 | 23.14 |
01:06 ET | 200 | 23.145 |
01:08 ET | 400 | 23.14 |
01:10 ET | 600 | 23.1 |
01:12 ET | 600 | 23.09 |
01:14 ET | 1202 | 23.1 |
01:15 ET | 100 | 23.09 |
01:17 ET | 1555 | 23.12 |
01:19 ET | 100 | 23.11 |
01:21 ET | 755 | 23.13 |
01:24 ET | 100 | 23.15 |
01:26 ET | 500 | 23.14 |
01:28 ET | 100 | 23.14 |
01:30 ET | 500 | 23.205 |
01:32 ET | 2238 | 23.165 |
01:33 ET | 633 | 23.13 |
01:35 ET | 323 | 23.08 |
01:37 ET | 2261 | 23.09 |
01:39 ET | 200 | 23.18 |
01:42 ET | 1200 | 23.19 |
01:44 ET | 611 | 23.17 |
01:46 ET | 644 | 23.1913 |
01:48 ET | 600 | 23.2 |
01:50 ET | 1024 | 23.28 |
01:51 ET | 900 | 23.265 |
01:53 ET | 1743 | 23.32 |
01:55 ET | 5513 | 23.365 |
01:57 ET | 2513 | 23.291 |
02:00 ET | 200 | 23.31 |
02:02 ET | 1004 | 23.32 |
02:06 ET | 100 | 23.35 |
02:08 ET | 1720 | 23.295 |
02:09 ET | 800 | 23.3 |
02:11 ET | 100 | 23.28 |
02:13 ET | 1676 | 23.39 |
02:15 ET | 100 | 23.38 |
02:18 ET | 420 | 23.33 |
02:20 ET | 100 | 23.39 |
02:24 ET | 300 | 23.35 |
02:27 ET | 300 | 23.38 |
02:29 ET | 1400 | 23.33 |
02:31 ET | 935 | 23.33 |
02:33 ET | 600 | 23.3652 |
02:36 ET | 784 | 23.39 |
02:38 ET | 400 | 23.41 |
02:40 ET | 100 | 23.41 |
02:42 ET | 100 | 23.43 |
02:44 ET | 100 | 23.4 |
02:45 ET | 457 | 23.41 |
02:47 ET | 200 | 23.39 |
02:49 ET | 8100 | 23.45 |
02:51 ET | 700 | 23.39 |
02:56 ET | 6041 | 23.31 |
02:58 ET | 1417 | 23.33 |
03:00 ET | 1000 | 23.3 |
03:02 ET | 100 | 23.3 |
03:03 ET | 100 | 23.32 |
03:05 ET | 100 | 23.31 |
03:07 ET | 5589 | 23.28 |
03:09 ET | 1455 | 23.3 |
03:12 ET | 900 | 23.3 |
03:14 ET | 3168 | 23.29 |
03:16 ET | 300 | 23.285 |
03:18 ET | 800 | 23.295 |
03:20 ET | 358 | 23.32 |
03:21 ET | 762 | 23.33 |
03:23 ET | 799 | 23.3 |
03:25 ET | 1465 | 23.25 |
03:27 ET | 1275 | 23.28 |
03:30 ET | 941 | 23.29 |
03:32 ET | 750 | 23.2708 |
03:34 ET | 1160 | 23.275 |
03:36 ET | 550 | 23.295 |
03:38 ET | 300 | 23.3 |
03:39 ET | 1326 | 23.26 |
03:41 ET | 2923 | 23.23 |
03:43 ET | 4612 | 23.29 |
03:45 ET | 2092 | 23.34 |
03:48 ET | 3500 | 23.34 |
03:50 ET | 44832 | 23.42 |
03:52 ET | 12079 | 23.475 |
03:54 ET | 18621 | 23.47 |
03:56 ET | 9310 | 23.555 |
03:57 ET | 9033 | 23.53 |
03:59 ET | 106577 | 23.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Beam Therapeutics Inc | 1.9B | -13.3x | --- |
Galapagos NV | 1.9B | 53.7x | --- |
Genmab A/S | 15.6B | 19.1x | +22.71% |
Catalyst Pharmaceuticals Inc | 2.4B | 37.5x | --- |
Maravai LifeSciences Holdings Inc | 2.0B | -7.9x | --- |
BioCryst Pharmaceuticals Inc | 1.5B | -10.1x | --- |
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
---|---|
Revenue (TTM) | $352.6M |
Shares Outstanding | 82.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.85 |
EPS | $-1.76 |
Book Value | $12.02 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.